Emerging Biological Treatments in Inflammatory Bowel Diseases
Author:
Publisher
S. Karger AG
Subject
Gastroenterology,General Medicine
Reference31 articles.
1. Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2. Intravenous hydrocortisone premedication reduces antibodies to infliximab in Crohn's disease: A randomized controlled trial
3. Comparison of scheduled and episodic treatment strategies of infliximab in Crohn’s disease
4. Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial
5. Infliximab as Rescue Therapy in Severe to Moderately Severe Ulcerative Colitis: A Randomized, Placebo-Controlled Study
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Effectiveness of adalimumab for ulcerative colitis: A multicentre, retrospective study of clinical practice in Italy;Digestive and Liver Disease;2021-09
2. Gut Immunity and Inflammatory Bowel Disease;Pediatric Inflammatory Bowel Disease;2012-11-23
3. What can we learn about biofilm/host interactions from the study of inflammatory bowel disease;Journal of Clinical Periodontology;2011-02-16
4. Manipulation of Intestinal Microbial Flora for Therapeutic Benefit in Inflammatory Bowel Diseases: Review of Clinical Trials of Probiotics, Prebiotics and Synbiotics;Reviews on Recent Clinical Trials;2008-09-01
5. Type I interferons for induction of remission in ulcerative colitis;Cochrane Database of Systematic Reviews;2008-07-16
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3